Wellington Management Group’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,501,301
Closed -$89.8M 2035
2020
Q2
$89.8M Sell
1,501,301
-106,883
-7% -$6.6M 0.02% 554
2020
Q1
$95.5M Sell
1,608,184
-463,886
-22% -$27M 0.03% 472
2019
Q4
$114M Buy
2,072,070
+1,682,488
+432% +$62.8M 0.02% 537
2019
Q3
$11M Sell
389,582
-8,283
-2% -$304K ﹤0.01% 1133
2019
Q2
$13.2M Buy
397,865
+139,312
+54% +$4.35M ﹤0.01% 1123
2019
Q1
$8.79M Sell
258,553
-30,593
-11% -$973K ﹤0.01% 1238
2018
Q4
$7.92M Sell
289,146
-54,590
-16% -$1.41M ﹤0.01% 1251
2018
Q3
$10M Buy
+343,736
New +$9.7M ﹤0.01% 1278

Other funds holding PRNB

Wellington Management Group's PRNB Position: Q3 2020 in Review

Wellington Management Group sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 1,501,301 shares — an estimated $89.8M sold.

Wellington Management Group first reported a position in PRNB in Q3 2018 and held it in 8 quarters. The position peaked at $114M in Q4 2019. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Wellington Management Group reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Wellington Management Group sold 1,501,301 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $89.8M.
  • Wellington Management Group first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 8 quarters.
  • Wellington Management Group's Principia Biopharma Inc. Common Stock position peaked at $114M in Q4 2019.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Wellington Management Group's 13F filing for Q3 2020, filed 16 Nov 2020.